Arnold-Chiari malformation secondary prevention

Revision as of 20:44, 28 September 2019 by Fahimeh Shojaei (talk | contribs) (Created page with "__NOTOC__ {{Arnold-Chiari malformation}} {{CMG}}; {{AE}} {{Fs}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Arnold-Chiari malformation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Arnold-Chiari malformation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Case #2

Arnold-Chiari malformation secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Arnold-Chiari malformation secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Arnold-Chiari malformation secondary prevention

CDC on Arnold-Chiari malformation secondary prevention

Arnold-Chiari malformation secondary prevention in the news

Blogs on Arnold-Chiari malformation secondary prevention

Directions to Hospitals Treating Arnold-Chiari malformation

Risk calculators and risk factors for Arnold-Chiari malformation secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

References

Template:WH Template:WS